Bcl-7A antibody
Principal name
Bcl-7A antibody
Alternative names for Bcl-7A antibody
BCL7A, B-cell CLL/lymphoma 7 protein family member A
Ncbi ID
9606, NP_066273, NM_020993, NP_001019979, NM_001024808, NP_066273.1, NP_001019979.1, NP_084126.1, BC017640
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB)
Background of Bcl-7A antibody
- Kit Component:
- - KN302112G1, Bcl7a gRNA vector 1 in pCas-Guide vector
- KN302112G2, Bcl7a gRNA vector 2 in pCas-Guide vector
- KN302112D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Zani VJ, Asou N, Jadayel D, Heward JM, Shipley J, Nacheva E, Takasuki K, Catovsky D, Dyer MJ.
Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon.
Blood 1996 Apr 15;87(8):3124-34
PMID: 8605326.
BCL7A polyclonal antibody ( Cat # PAB6001 ) staining ( 0.5 µg/ml ) of HeLa lysate ( RIPA buffer, 35 µg total protein per lane ) . Primary incubated for 1 hour. Detected by western blot using chemiluminescence.
Hum. Fetal Heart; Host:Rabbit. Target Name:BCL7A. Sample Tissue:Human Fetal Heart. Antibody Dilution: 1.0ug/ml.; BCL7A antibody - middle region (ARP57507_P050) in Hum. Fetal Heart cells using Western Blot
Hum. Fetal Brain; Host:Rabbit. Target Name:BCL7A. Sample Tissue:Human Fetal Brain. Antibody Dilution: 1.0ug/ml.; BCL7A antibody - middle region (ARP57507_P050) in Hum. Fetal Brain cells using Western Blot
Human Lung; WB Suggested Anti-BCL7A Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Human Lung; BCL7A antibody - middle region (ARP57507_P050) in Human Lung cells using Western Blot
Human 721_B; WB Suggested Anti-BCL7A Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: 721_B cell lysate. BCL7A is supported by BioGPS gene expression data to be expressed in 721_B.; BCL7A antibody - middle region (ARP57508_P050) in Human 721_B cells using Western Blot
BCL7A Antibody (N-term) (Cat. #AP50360PU-N) western blot analysis in NCI-H292 cell line lysates (35µg/lane).This demonstrates the BCL7A antibody detected the BCL7A protein (arrow).
TA302703 staining (0.5µg/ml) of HeLa lysate (RIPA buffer, 35µg total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.
Western blot analysis of extracts from HuvEc cells, using BCL7A antibody.The lane on the right is treated with the synthesized peptide.
WB Suggested Anti-BCL7A Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: 721_B cell lysateBCL7A is supported by BioGPS gene expression data to be expressed in 721_B
WB Suggested Anti-BCL7A Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:1562500; Positive Control: Human Lung
Host:Rabbit; Target Name:BCL7A; Sample Tissue:Human Fetal Brain; Antibody Dilution: 1.0 ug/ml
Host:Rabbit; Target Name:BCL7A; Sample Tissue:Human Fetal Heart; Antibody Dilution: 1.0 ug/ml
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA302703 | Bcl-7A (C-term) antibody |
||||||
| Goat Polyclonal Antibody against BCL7A | |||||||
 |
Goat | Ig Fraction | Bov, Can, Hu, Ms, Por, Rt | WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA313240 | Bcl-7A antibody |
||||||
| Rabbit polyclonal anti-BCL7A antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP50360PU-N | Bcl-7A (N-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP310489 | Bcl-7A (transcript variant 2) |
||||
| Recombinant protein of human B-cell CLL/lymphoma 7A (BCL7A), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY422541 | BCL7A overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR200442L2V | Lenti ORF particles, Bcl7a (GFP-tagged) - Mouse B-cell CLL/lymphoma 7A (cDNA clone MGC:28969 IMAGE:4482250), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€840.00
|
|
| OriGene Technologies, Inc. | ||
| MR200442L1V | Lenti ORF particles, Bcl7a (Myc-DDK-tagged) - Mouse B-cell CLL/lymphoma 7A (cDNA clone MGC:28969 IMAGE:4482250), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€740.00
|
|
| OriGene Technologies, Inc. | ||